New hope for lung cancer patients when treatment fails and cancer spreads to brain

NCT ID NCT07398599

Summary

This study is testing a more intensive treatment for people with advanced lung cancer where the disease has spread to the lining of the brain and spinal cord (leptomeningeal metastasis) after their previous targeted therapy stopped working. Researchers want to see if giving a higher dose of the targeted pill, combined with a chemotherapy injection directly into the spinal fluid and an IV drug that blocks blood vessel growth, can better control the cancer in the brain. They will also check if genetic markers in the spinal fluid can help predict how well patients might respond to this new approach.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Second Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, Jiangxi, China

Conditions

Explore the condition pages connected to this study.